ACG’s DAVID SUN LECTURE
Gary W. Falk, MD, MS, FACG
Screening and Surveillance of Barrett’s Esophagus: Where Are We Now and What Does the Future Hold?
Saturday, October 14 • 10:00-10:30 am • Valencia Ballroom
Hear Dr. Gary Falk define best practices and review what is on the horizon in screening and surveillance of Barrett’s esophagus when he presents the ACG David Sun Lecture.
Dr. Falk has been involved in clinical research in Barrett’s esophagus, gastroesophageal reflux disease, Helicobacter pylori, esophageal motility disorders, advanced esophageal imaging and therapeutics, and eosinophilic esophagitis, that has resulted in over 150 peer reviewed publications and NIH and non-NIH grants. He is currently involved in translational research studies in collaboration with basic scientists in cancer biology and pathobiology to study the role of inflammatory mediators in eosinophilic esophagitis and cell of origin of Barrett’s esophagus. Research in eosinophilic esophagitis is also focusing on clinical trials of novel therapeutic agents, clinical and biologic aspects of pediatric to adult transition, and participation in the Consortium of Eosinophilic Gastrointestinal Disease Researchers consortium. Dr. Falk is currently Professor of Medicine and co-director, GI Motility/Physiology Laboratory at the Hospital of the University of Pennsylvania.
About the David Sun Lecture: The David Sun Lectureship in Postgraduate Education was established by Mrs. Sun in memory of her husband. Dr. Sun died at the peak of his career. He was an outstanding gastroenterologist and investigator. The speaker, with a distinguished background in gastroenterology or an allied field, is chosen by the President and Course Directors of the Postgraduate Program subject to the approval of the Board of Trustees.